SPAC · Liquidated
Enphys Acquisition Corp.
Enphys Acquisition Corp. is a blank-check company (SPAC) that raised $300M in its initial public offering on Oct 7, 2021, listing on New York Stock Exchange. It did not complete a business combination and liquidated around Oct 10, 2024, returning the trust to public shareholders. Credit Suisse led the IPO, with BTIG. Brown Rudnick advised the SPAC and Davis Polk advised the underwriters on the IPO.
- Status
- Liquidated
- IPO date
- Oct 7, 2021
- IPO size
- $300M
- IPO exchange
- New York Stock Exchange
- IPO underwriters
- Credit Suisse and BTIG
- SPAC counsel (IPO)
- Brown Rudnick and Walkers
- Underwriters' counsel (IPO)
- Davis Polk
More on this SPAC for subscribers
- Trust balance and value per share
- Liquidation deadline and extension history
- Analyst notes from the filings
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
- IPO prospectus (424B4) Oct 7, 2021
- All filings on EDGAR CIK 1850502
Other SPAC IPOs from 2021
- IX Acquisition Corp.Oct 8, 2021 · $200M
- Schultze Special Purpose Acquisition Corp. IIOct 8, 2021 · $150M
- Phoenix Biotech Acquisition Corp.Oct 8, 2021 · $155M
- Avalon Acquisition Inc.Oct 7, 2021 · $180M
- Focus Impact BH3 Acquisition Co (formerly Crixus BH3 Acquisition Co)Oct 6, 2021 · $200M
- Parsec Capital Acquisitions Corp.Oct 6, 2021 · $75M